Concepedia
Statistics
Publications
29
Citations
2.2K
H-Index
21
Active since
1995
Affiliations
Sanofi (United States)(Current)
Sanofi (France)
Dana-Farber Cancer Institute
Harvard University
Massachusetts General Hospital
Frank Campana is an author at Sanofi (United States) specializing in medicine, multiple myeloma therapy, and oncology.
Publications per year
1995–2022
Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM): a randomised, multicentre, open-label, phase 3 study
Michel Attal, Paul G. Richardson, S. Vincent Rajkumar et al. · The Lancet · 2019 · 636 citations
Medicine, Hematology, Pharmacotherapy +15
Overall Survival with Brentuximab Vedotin in Stage III or IV Hodgkin’s Lymphoma
Stephen M. Ansell, John Radford, Joseph M. Connors et al. · New England Journal of Medicine · 2022 · 328 citations · Full text
Medicine, Oncology, Pharmacotherapy +15
A phase 1b study of isatuximab plus lenalidomide and dexamethasone for relapsed/refractory multiple myeloma
Thomas G. Martin, Rachid Baz, Don M. Benson et al. · Blood · 2017 · 166 citations · Full text
Medicine, Hematology, Pharmacotherapy +13
Phase II study of the PI3K inhibitor pilaralisib (SAR245408; XL147) in patients with advanced or recurrent endometrial carcinoma
Ursula A. Matulonis, Ignace Vergote, Floor Backes et al. · Gynecologic Oncology · 2014 · 119 citations
Medicine, Oncology, Pharmacology +11
Efficacy of Trastuzumab in Routine Clinical Practice and After Progression for Metastatic Breast Cancer Patients: The Observational Hermine Study
Jean-Marc Extra, Eric C. Antoine, Anne Vincent‐Salomon et al. · The Oncologist · 2010 · 110 citations · Full text
1–5 of 29